Immune Responses to Dystrophin: Implications for Gene Therapy of Duchenne Muscular Dystrophy

Gene Therapy - United Kingdom
doi 10.1038/sj.gt.3301259
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Gene Therapy for Duchenne Muscular Dystrophy

Archives of Neurology
2007English

Genome Editing Gene Therapy for Duchenne Muscular Dystrophy

Journal of Neuromuscular Diseases
Neurology
2015English

150. Ex Vivo Gene Therapy of Duchenne Muscular Dystrophy Using iPSCs From Duchenne Muscular Dystrophy Patients

Molecular Therapy
Molecular MedicineMolecular BiologyPharmacologyMedicineGeneticsDrug Discovery
2014English

Progress Toward Gene Therapy of Duchenne Muscular Dystrophy

Seminars in Neurology
Neurology
1999English

Dystrophin Dp116: A Yet to Be Investigated Product of the Duchenne Muscular Dystrophy Gene

Genes
Genetics
2017English

Duchenne Muscular Dystrophy Gene Therapy: Lost in Translation?

Research and Reports in Biology
2011English

Dual Exon Skipping in Myostatin and Dystrophin for Duchenne Muscular Dystrophy

BMC Medical Genomics
Genetics
2011English

Duchenne Muscular Dystrophy

Physiotherapy
Physical TherapySports TherapyRehabilitation
1990English

Duchenne Muscular Dystrophy

English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy